<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02993653</url>
  </required_header>
  <id_info>
    <org_study_id>VINPI1501</org_study_id>
    <nct_id>NCT02993653</nct_id>
  </id_info>
  <brief_title>Intensity-modulated Radiotherapy Protocol in Cervix Cancer</brief_title>
  <official_title>Definitive Treatment Protocol for High-dose Intensity-modulated Radiotherapy (IMRT) With Intracavitary Radiotherapy in Locally Advanced Cervical Cancer: A Phase II Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul St. Mary's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul St. Mary's Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Definitive treatment protocol for high-dose intensity-modulated radiotherapy (IMRT) with
      intracavitary radiotherapy in locally advanced cervical cancer: A phase II trial
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Radiotherapy

        1. intensity-modulated radiotherapy of whole pelvis: 60 Gy in 30 fx Re-simulation with
           pelvic Magnetic resonance imaging at 46 Gy in 23 fx and intensity-modulated radiotherapy
           on the gross cervical and nodal tumor (initially Positron emission tomography-positive),
           14 Gy in 7 fx

        2. intensity-modulated radiotherapy boost of gross cervical tumor or Intra-cavitary
           radiotherapy (ICR)

             -  Re-staging pelvic Magnetic resonance imaging , if complete response occurs
                Intra-cavitary radiotherapy to A point, 25 Gy in 5 fx for 2 weeks

             -  Re-staging pelvic Magnetic resonance imaging I, partial response or stable disease
                occurs intensity-modulated radiotherapy boost , 10 Gy in 4 fx to the gross cervical
                tumor for 1 week
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Progression-free survival</measure>
    <time_frame>30 months</time_frame>
    <description>Progression means locoregional recurrence, distant metastasis, and local tumor pregression</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall survival</measure>
    <time_frame>30 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment-related adverse events are assessed by CTCAE v4.0.</measure>
    <time_frame>acute within 3 months and chronic after 3 months after radiotherapy</time_frame>
    <description>Toxicity</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Radiation</condition>
  <arm_group>
    <arm_group_label>Intensity-modulated radiotheapy arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intensity-modulated radiotheapy with stereotactic boost or intracavitary radiotherapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>High-dose Intensity-modulated radiotherapy</intervention_name>
    <description>Pelvic High-dose Intensity-modulated radiotherapy with stereotactic radiotherapy or intracavitary radiotherapy</description>
    <arm_group_label>Intensity-modulated radiotheapy arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. FIGO II-IVA Patients with untreated and histologically confirmed carcinoma of the
             uterine cervix

          2. Patients with Eastern Cooperative Oncology Group (ECOG) Performance Status of 0, 1

          3. Patients with adequate bone marrow function: Absolute nutrophil count (ANC) greater
             than or equal to 1,500/mcl, platelets greater than or equal to 100,000/mcl at the
             beginning

          4. Patients with adequate renal function: creatinine equal to or less than 2.0 mg/mL

          5. Patients who have signed an approved informed consent and authorization

        Exclusion Criteria:

          1. Patients with recurrent cervical cancer

          2. Patients who have diagnosis of other malignance tumors except papillary or follicular
             thyroid cancer or skin cancer

          3. Patients with metastatic lymphadenopathies other than pelvis (e.g. inguinal,
             paraaortic, supraclavicular, or mediastinal node)

          4. Patients with distant organ metastasis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jong Hoon Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Vincent's Hospital, South Korea</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jong Hoon Lee, MD</last_name>
    <phone>+82-010-8607-1269</phone>
    <email>koppul@catholic.ac.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Lee Jong Hoon</name>
      <address>
        <city>Suwon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jong Hoon Lee</last_name>
      <email>koppul@catholic.ac.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 11, 2016</study_first_submitted>
  <study_first_submitted_qc>December 14, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 15, 2016</study_first_posted>
  <last_update_submitted>December 14, 2016</last_update_submitted>
  <last_update_submitted_qc>December 14, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul St. Mary's Hospital</investigator_affiliation>
    <investigator_full_name>Jong Hoon Lee</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

